Correlation Between HCW Biologics and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and DiaMedica Therapeutics, you can compare the effects of market volatilities on HCW Biologics and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and DiaMedica Therapeutics.
Diversification Opportunities for HCW Biologics and DiaMedica Therapeutics
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between HCW and DiaMedica is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of HCW Biologics i.e., HCW Biologics and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between HCW Biologics and DiaMedica Therapeutics
Given the investment horizon of 90 days HCW Biologics is expected to under-perform the DiaMedica Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, HCW Biologics is 1.14 times less risky than DiaMedica Therapeutics. The stock trades about -0.18 of its potential returns per unit of risk. The DiaMedica Therapeutics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 307.00 in DiaMedica Therapeutics on March 7, 2024 and sell it today you would lose (19.00) from holding DiaMedica Therapeutics or give up 6.19% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
HCW Biologics vs. DiaMedica Therapeutics
Performance |
Timeline |
HCW Biologics |
DiaMedica Therapeutics |
HCW Biologics and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with HCW Biologics and DiaMedica Therapeutics
The main advantage of trading using opposite HCW Biologics and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.HCW Biologics vs. Artelo Biosciences | HCW Biologics vs. Nutriband | HCW Biologics vs. SAB Biotherapeutics |
DiaMedica Therapeutics vs. Artelo Biosciences | DiaMedica Therapeutics vs. Nutriband | DiaMedica Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |